Mikacas 250mg Injection
Marketer
Casca Remedies Pvt Ltd
Salt Composition
Amikacin (250mg)
Overview Mikacas 250mg Injection
Cefamix 250mg Injection combats a broad spectrum of bacterial infections, including those affecting the urinary tract, skeletal system, lungs (such as pneumonia), central nervous system, and bloodstream. This antibiotic is also prophylactically administered to hospitalized individuals. Its mechanism involves inhibiting bacterial proliferation. Administered intravenously (IV drip) or intramuscularly by a healthcare professional, self-injection is strictly prohibited. Adherence to the prescribed dosage schedule is crucial; incomplete treatment can result in infection recurrence or exacerbation. Common adverse reactions include injection site inflammation and elevated blood urea nitrogen (BUN) levels. Persistent side effects or treatment inefficacy necessitate medical consultation. High-dose therapy may rarely cause vertigo, nephrotoxicity, and ototoxicity. Regular monitoring of renal function, hearing, and urine analysis may be implemented. This medication is contraindicated during pregnancy. Disclose pregnancy, pregnancy planning, or breastfeeding to your physician.
Uses of Mikacas 250mg Injection
Infections caused by bacteria
Major Benefits of Mikacas 250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Mikacas 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikacas 250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Mikacas 250mg Injection works:
The antibiotic injection, Mikacas 250mg, inhibits bacterial proliferation by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concurrent use of Mikacas 250mg Injection and alcohol.
PregnancyCONSULT YOUR DOCTOR
Administering Mikacas 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
Administration of Mikacas 250mg Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Administration of Mikacas 250mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
The use of Mikacas 250mg Injection requires careful consideration in individuals with impaired kidney function. Dosage modification for Mikacas 250mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Mikacas 250mg Injection is likely safe for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary. Physician consultation is advised.
What if you forget to take Mikacas 250mg Injection :
Should you forget a scheduled dose of Mikacas 250mg Injection, seek advice from your physician.
Facts to Know About Mikacas 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Actions | Aminoglycoside antibiotics |
3,018 People bought this recently